Gynecology Trials
NRG-GY006
NRG-GY006 – a randomized phase II trial of radiation therapy and cisplatin alone or in combination with intravenous tripine in women with newly diagnosed bulky stage IB2, stage II, IIIB, or IVA cancer of the uterine cervix or stage II-IVA vaginal cancer.
-
What type of cancer? What stage?
- Cervix or vaginal cancer.
-
Who is eligible?
- Women who will be treated with radiation.
-
How will I be treated?
- Patients will be randomized to receive Triapine, along with standard curative therapy. Tripine is a biologic drug, a ribonucleotide reductase inhibitor.
For physicians: more information about this specific trial at clinicaltrials.gov.
-
Metairie, LA 70006
504.988.6300 More information -
Metairie, LA 70006
504.456.5000 More information -
Metairie, LA 70006
504.503.6289 More information
-
When you own a house, you take care of it with regular maintenance. When you own a car, you take it to ...
Continue Reading -
Let’s start with some good news: colorectal cancer diagnoses and mortality rates are on the decline. ...
Continue Reading -
At your last checkup, your primary care provider recommended you schedule a breast cancer screening this ...
Continue Reading -
Each year in the U.S., nearly 2 million people are diagnosed with some type of cancer. If a friend or ...
Continue Reading -
If you’ve been diagnosed with cancer, you want the care of a team of experts. You’ll find that through ...
Continue Reading